
                     
                     
                     Drug Interactions
                     
                     
                        
                           
                           
                           Use with Allopurinol
                           
                              One of the pathways for inactivation of azathioprine is inhibited by allopurinol. Patients receiving azathioprine tablets and allopurinol concomitantly should have a dose reduction of azathioprine tablets, to approximately 1/3 to 1/4 the usual dose. It is recommended that a further dose reduction or alternative therapies be considered for patients with low or absent TPMT activity receiving azathioprine tablets and allopurinol because both TPMT and XO inactivation pathways are affected. See CLINICAL PHARMACOLOGY, WARNINGS, PRECAUTIONS: Laboratory Tests and ADVERSE REACTIONSÂ  sections.
                           
                           
                        
                     
                     
                        
                           
                           
                           Use with Aminosalicylates
                           
                              There is in vitro evidence that aminosalicylate derivatives (e.g., sulphasalazine, mesalazine, or olsalazine) inhibit the TPMT enzyme. Concomitant use of these agents with azathioprine tablets should be done with caution.
                           
                           
                        
                     
                     
                        
                           
                           
                           Use with Other Agents Affecting Myelopoiesis
                           
                              Drugs which may affect leukocyte production, including cotrimoxazole, may lead to exaggerated leukopenia, especially in renal transplant recipients.
                           
                           
                        
                     
                     
                        
                           
                           
                           Use with Angiotensin-Converting Enzyme Inhibitors
                           
                              The use of angiotensin-converting enzyme inhibitors to control hypertension in patients on azathioprine has been reported to induce anemia and severe leukopenia. 
                           
                           
                        
                     
                     
                        
                           
                           
                           Use with Warfarin
                           
                              Azathioprine tablets may inhibit the anticoagulant effect of warfarin.
                           
                           
                        
                     
                  
               